secwatch.observer — SEC 8-K summary
======================================

Issuer:     FibroBiologics, Inc. (FBLG)
CIK:        0001958777
Form:       8-K
Filed at:   2025-05-05T23:59:59+00:00
Accession:  0001641172-25-008680
Event type: leadership
Sentiment:  negative
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

FibroBiologics Interim CFO Robert Hoffman resigns effective May 14, 2025
------------------------------------------------------------------------

- Robert E. Hoffman resigned as Interim CFO effective May 14 to pursue another opportunity.
- Hoffman will remain on the Board of Directors as a Class I director.
- Company will initiate a search for a new CFO successor.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1958777/000164117225008680/0001641172-25-008680-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1958777/000164117225008680/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-008680

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer